2/5
09:39 am
idxx
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market [Yahoo! Finance]
Low
Report
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market [Yahoo! Finance]
2/5
07:02 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $800.00 price target on by analysts at Barclays PLC.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $800.00 price target on by analysts at Barclays PLC.
2/4
08:20 am
idxx
IDEXX: A Great Business Trapped By A Demanding Valuation [Seeking Alpha]
Low
Report
IDEXX: A Great Business Trapped By A Demanding Valuation [Seeking Alpha]
2/3
08:16 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/2
11:02 pm
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $800.00 price target on by analysts at BTIG Research.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $800.00 price target on by analysts at BTIG Research.
2/2
05:32 pm
idxx
Idexx CEO Shift And AI Imaging Launch Shape Growth Expectations [Yahoo! Finance]
Low
Report
Idexx CEO Shift And AI Imaging Launch Shape Growth Expectations [Yahoo! Finance]
2/2
01:00 pm
idxx
IDEXX Laboratories Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
IDEXX Laboratories Q4 Earnings Call Highlights [Yahoo! Finance]
2/2
11:48 am
idxx
Idexx targets $4.632B–$4.720B revenue for 2026 as innovation drives 8%–10% CAG diagnostics growth [Seeking Alpha]
Low
Report
Idexx targets $4.632B–$4.720B revenue for 2026 as innovation drives 8%–10% CAG diagnostics growth [Seeking Alpha]
2/2
11:12 am
idxx
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise [Yahoo! Finance]
Low
Report
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise [Yahoo! Finance]
2/2
08:30 am
idxx
IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics [Yahoo! Finance]
Medium
Report
IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics [Yahoo! Finance]
2/2
06:59 am
idxx
Idexx: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Idexx: Q4 Earnings Snapshot [Yahoo! Finance]
2/2
06:40 am
idxx
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
Medium
Report
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]
2/2
06:30 am
idxx
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
Medium
Report
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
1/31
09:57 am
idxx
IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook [Yahoo! Finance]
Medium
Report
IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook [Yahoo! Finance]
1/30
06:36 pm
idxx
IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
Medium
Report
IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
1/25
09:47 am
idxx
Conestoga Mid Cap Composite Q4 2025 Commentary [Seeking Alpha]
Low
Report
Conestoga Mid Cap Composite Q4 2025 Commentary [Seeking Alpha]
1/15
07:02 pm
idxx
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus [Yahoo! Finance]
Low
Report
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus [Yahoo! Finance]
1/15
07:15 am
idxx
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
Low
Report
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
1/15
07:00 am
idxx
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
Low
Report
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
1/14
04:01 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
1/13
08:59 am
idxx
IDEXX appoints Michael Erickson as CEO [Seeking Alpha]
Low
Report
IDEXX appoints Michael Erickson as CEO [Seeking Alpha]
1/13
08:57 am
idxx
IDEXX Announces CEO Succession [Yahoo! Finance]
Low
Report
IDEXX Announces CEO Succession [Yahoo! Finance]
1/13
08:30 am
idxx
IDEXX Announces CEO Succession
Low
Report
IDEXX Announces CEO Succession
1/13
08:01 am
idxx
IDEXX Laboratories (IDXX): From a Detractor to a Revivor [Yahoo! Finance]
Low
Report
IDEXX Laboratories (IDXX): From a Detractor to a Revivor [Yahoo! Finance]
1/10
07:02 pm
idxx
Is It Too Late To Consider Buying IDEXX Laboratories (IDXX) After A 71% One Year Rally [Yahoo! Finance]
Low
Report
Is It Too Late To Consider Buying IDEXX Laboratories (IDXX) After A 71% One Year Rally [Yahoo! Finance]